Zachary Sutton: Translating the 2026 KDIGO Guideline Into Practice
Zachary Sutton, Director of Medical Operations, Transplant Program Coordinator at Carolina Nephrology, PA, Adjunct Assistant Professor at Medical University of South Carolina, shared a post on LinkedIn about a recent article by Susan Hedayati et al, published in Annals of Internal Medicine, adding:
“The 2026 KDIGO anemia guideline updates how we manage anemia in CKD by emphasizing individualized treatment over a one-size-fits-all approach.
Key takeaways include:
- Use ferritin and TSAT to guide iron therapy, with IV iron preferred for patients on hemodialysis
- Address reversible causes of anemia before starting ESA or HIF-PHI therapy
- ESAs remain the preferred first-line therapy over HIF-PHIs
- Individualize when to initiate ESA therapy based on symptoms, comorbidities, and patient preferences
- Maintain hemoglobin below 11.5 g/dL during ESA treatment
For nephrology teams, the message is clear: treat the patient, not simply the hemoglobin number.
The updated guideline gives us a more personalized framework for balancing iron replacement, anemia symptoms, transfusion avoidance, and treatment risk across the CKD spectrum.
A useful update for anyone managing patients with advanced CKD or dialysis.”
Title: Evaluation and Management of Anemia in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2026 Clinical Practice Guideline
Authors: S. Susan Hedayati, Jodie L. Babitt, Jeffrey S. Berns, Biykem Bozkurt, Rebecca S. Cheung, Yarieli Cuevas, Emmanuel E. Effa, Michele F. Eisenga, Steven Fishbane, Yelena Z. Ginzburg, Volker H. Haase, Siah Kim, Jose A. Moura-Neto, Patrick Rossignol, Manisha Sahay, Tetsuhiro Tanaka, Angela Yee-Moon Wang, David C. Wheeler, Karen A. Robinson, Lisa M. Wilson, Renée F. Wilson, Jennifer M. King, Amy Earley, Elie A. Akl, Marcello Tonelli, Evi V. Nagler
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke